Noncommercial US Funders’ Policies on Trial Registration, Access to Summary Results, and Individual Patient Data Availability

Authors:

Abstract
Over the past 20 years,1 national and international initiatives have been launched to improve clinical trial registration and reporting.2-4 Incomplete information about existing research is an underlying cause of research waste5 and undermines credible, efficient production of research to support health care decision making.6 Trial registries afford the means to capture a minimum, structured information set from all ongoing and completed clinical trials in humans and to make these publicly accessible. Efforts in the United States have been greatly enhanced by the creation of ClinicalTrials.gov in 2000 by the National Institutes of Health (NIH), which expanded to incorporate results reporting in 2008; ClinicalTrials.gov currently houses approximately a quarter of a million trial records, representing about two-thirds of clinical trials registered globally.7

This publication has 15 references indexed in Scilit: